Cargando…
Refining precision cancer therapy in ALK-positive NSCLC
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444055/ https://www.ncbi.nlm.nih.gov/pubmed/30737082 http://dx.doi.org/10.1016/j.ebiom.2019.01.059 |
| _version_ | 1783407951024750592 |
|---|---|
| author | Lin, Jessica J. Shaw, Alice T. |
| author_facet | Lin, Jessica J. Shaw, Alice T. |
| author_sort | Lin, Jessica J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6444055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64440552019-04-11 Refining precision cancer therapy in ALK-positive NSCLC Lin, Jessica J. Shaw, Alice T. EBioMedicine Commentary Elsevier 2019-02-06 /pmc/articles/PMC6444055/ /pubmed/30737082 http://dx.doi.org/10.1016/j.ebiom.2019.01.059 Text en © 2019 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Lin, Jessica J. Shaw, Alice T. Refining precision cancer therapy in ALK-positive NSCLC |
| title | Refining precision cancer therapy in ALK-positive NSCLC |
| title_full | Refining precision cancer therapy in ALK-positive NSCLC |
| title_fullStr | Refining precision cancer therapy in ALK-positive NSCLC |
| title_full_unstemmed | Refining precision cancer therapy in ALK-positive NSCLC |
| title_short | Refining precision cancer therapy in ALK-positive NSCLC |
| title_sort | refining precision cancer therapy in alk-positive nsclc |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444055/ https://www.ncbi.nlm.nih.gov/pubmed/30737082 http://dx.doi.org/10.1016/j.ebiom.2019.01.059 |
| work_keys_str_mv | AT linjessicaj refiningprecisioncancertherapyinalkpositivensclc AT shawalicet refiningprecisioncancertherapyinalkpositivensclc |